Clinical Trials Insight: 700032848
Phase of Trial: Phase I
Latest Information Update: 05 Feb 2009
At a glance
- Drugs Censavudine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Oncolys BioPharma
- 05 Feb 2009 The first patient was dosed on 5 Jan 2009, according to an Oncolys BioPharma media release.
- 05 Jan 2009 Status changed from planning to recruiting, first patient has been dosed, according to an Oncolys BioPharma media release.
- 22 Apr 2008 New trial record.